Securities and Finance

Self-Reporting under SEC's MCDC Initiative

The SEC has been encouraging municipal securities issuers and underwriters to self-report under the Municipalities Continuing Disclosure Cooperation Initiative ("MCDC Initiative"). The initiative is intended to address "possible violations involving materially inaccurate statements relating to prior compliance with the continuing disclosure obligations specified in Rule 15c2-12 under the Securities Exchange Act of 1934." Issuers and underwriters frequently face important decisions as to whether lack of continuing disclosure with regard to certain items would constitute a "materially inaccurate misstatement" in the SEC's view.

Clients ask us to assist with actual or potential SEC investigations into the materiality of either disclosures made by the issuer or underwriter or the lack of ongoing disclosure by the issuer of information that the SEC may believe is material.

NERA's work in these cases involves a careful analysis of materiality using event studies as well as analysis of individual trade data and matrix pricing. An evaluation of the market efficiency of the security at issue is also an important aspect of the analysis to show whether the information would have been important enough to investors as to change the value of the securities. NERA experts also assist counsel in addressing claims as to whether bond prices moves or would have moved in response to a timely disclosure as well as opine on the size of the price move and whether it differs from the bond price move one typically sees on a day-to-day basis.

Name Title Location Phone Email
Lucy P. Allen Managing Director New York City +1 212 345 5913
Dr. Patrick Conroy Managing Director New York City +1 212 345 1466
Dr. Vinita Juneja Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice
New York City
+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314
Dr. Denise Neumann Martin Managing Director New York City +1 212 345 5296
Dr. Faten Sabry Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
+1 212 345 3285
+44 20 7659 8618
Dr. David Tabak Managing Director New York City +1 212 345 2176
Adam Warren Managing Director Chicago +1 (312) 573-2821
Dr. Jordan Milev Associate Director New York City +1 212 345 5516
Dr. Stephanie Plancich Associate Director New York City +1 212 345 7719
Dr. Andrew Carron Affiliated Consultant New York City
+1 212 345 5407
+44 20 7659 8500
Dr. Marcia Kramer Mayer Affiliated Consultant New York City +1 212 345 2196
Title Type Author
How COVID-19 Impact Analysis May Shape MAE Disputes Published Article Dr. David Tabak and Edward Flores
COVID-19, MAEs, and Preliminary Evidence of Disproportionate Impacts Within Industrie... Brief Dr. David Tabak and Edward Flores
Corruption and Fraud in Financial Markets: Malpractice, Misconduct, and Manipulation Book Dr. Ai Deng, et at.
Hey Google: When Did People Stop Going to Work? White Paper By Dr. Faten Sabry, Linh Nguyen, and Aakash Bhalothia
Economic and Financial Analyses in Australian Securities Litigation in the Wake of TP... White Paper Dr. David Tabak and Dr. Will Taylor
S&P 500 Index: Daily Price Movements Brief Dr. David Tabak and Edward Flores
Recent Trends in Securities Class Action Litigation: Q1 2020 Update White Paper Janeen McIntosh.and Svetlana Starykh
How Are Different Types of Stocks Weathering COVID-19? Published Article By Dr. Jordan Milev
Analyzing Value Changes between Signing and Closing in Delaware Appraisal Actions White Paper Jonathan Polonsky
Trends in Canadian Securities Class Actions: 2019 Update Report Bradley A. Heys, Robert Patton, Jielei Mao